![Sven Rohmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sven Rohmann
Chairman at Inprother ApS
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Hans Preusting | M | 62 | 3 years | |
Peter Johannes Holst | M | - |
Inprother ApS
![]() Inprother ApS BiotechnologyHealth Technology Inprother ApS is a biotechnology company based in Copenhagen, Denmark. The Danish company aims to develop novel immunotherapies that target the human endogenous retroviruses (HERVs) as tumor-specific antigens. The company is funded by the Novo Nordisk Bioinnovation Institute and by grants from the Danish Innovation Fund and Eurostars. Inprother has put in place a world-class scientific team and created an emerging product development pipeline, including a leading program targeted to enter clinics in 2024. Inprother's approach is based on the research of founder and CTO, Dr. Peter Holst, and CTO, Dr. Anne-Marie Andersson. The company was founded in 2011 by Peter Johannes Holst. Jordi Naval has been the CEO of the company since 2021. | 13 years |
Dharminder Singh Chahal | M | 48 | 3 years | |
Andrea van Elsas | M | 58 | 3 years | |
Nicolaj Højer Nielsen | M | - |
Inprother ApS
![]() Inprother ApS BiotechnologyHealth Technology Inprother ApS is a biotechnology company based in Copenhagen, Denmark. The Danish company aims to develop novel immunotherapies that target the human endogenous retroviruses (HERVs) as tumor-specific antigens. The company is funded by the Novo Nordisk Bioinnovation Institute and by grants from the Danish Innovation Fund and Eurostars. Inprother has put in place a world-class scientific team and created an emerging product development pipeline, including a leading program targeted to enter clinics in 2024. Inprother's approach is based on the research of founder and CTO, Dr. Peter Holst, and CTO, Dr. Anne-Marie Andersson. The company was founded in 2011 by Peter Johannes Holst. Jordi Naval has been the CEO of the company since 2021. | 6 years |
J. Robert Coleman | M | - |
Inprother ApS
![]() Inprother ApS BiotechnologyHealth Technology Inprother ApS is a biotechnology company based in Copenhagen, Denmark. The Danish company aims to develop novel immunotherapies that target the human endogenous retroviruses (HERVs) as tumor-specific antigens. The company is funded by the Novo Nordisk Bioinnovation Institute and by grants from the Danish Innovation Fund and Eurostars. Inprother has put in place a world-class scientific team and created an emerging product development pipeline, including a leading program targeted to enter clinics in 2024. Inprother's approach is based on the research of founder and CTO, Dr. Peter Holst, and CTO, Dr. Anne-Marie Andersson. The company was founded in 2011 by Peter Johannes Holst. Jordi Naval has been the CEO of the company since 2021. | 1 years |
Lotta Ferm | F | 58 | 3 years | |
Johan Lund | M | 67 |
Tcer AB
| 5 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert A. Verhagen | M | 55 | 3 years | |
Yvon Bastien | M | 77 | 2 years | |
Theodore Witek | M | 67 | - | |
Gary Littlejohn | M | 68 | 1 years | |
Gunnar Magnus Modee Persson | M | 64 | 5 years | |
Stace L. Wills | M | 55 | 2 years | |
Sylwester Cacek | M | 63 | 5 years | |
Steve Demas | M | - | 4 years | |
George J. Anders | M | - | - | |
Michael Oredsson | M | 64 | 3 years | |
Peter Hein | M | 67 | 1 years | |
Veronika Kandziora | F | - | 2 years | |
Peter Suenaert | M | 56 | 1 years | |
Zbigniew Olgierd Markowski | M | 70 | - | |
Patrick Charles Frankham | M | 53 | 1 years | |
Jordi Naval | M | - |
Inprother ApS
![]() Inprother ApS BiotechnologyHealth Technology Inprother ApS is a biotechnology company based in Copenhagen, Denmark. The Danish company aims to develop novel immunotherapies that target the human endogenous retroviruses (HERVs) as tumor-specific antigens. The company is funded by the Novo Nordisk Bioinnovation Institute and by grants from the Danish Innovation Fund and Eurostars. Inprother has put in place a world-class scientific team and created an emerging product development pipeline, including a leading program targeted to enter clinics in 2024. Inprother's approach is based on the research of founder and CTO, Dr. Peter Holst, and CTO, Dr. Anne-Marie Andersson. The company was founded in 2011 by Peter Johannes Holst. Jordi Naval has been the CEO of the company since 2021. | 2 years |
Albert Beraldo | M | - | 1 years | |
Slawomir Ludwikowski | M | 65 | - | |
Margareth Jorvid | F | 63 | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 13 | 48.15% |
Sweden | 10 | 37.04% |
Denmark | 4 | 14.81% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sven Rohmann
- Personal Network